Coeptis Therapeutics Holdings, Inc.COEPEarnings & Financial Report
Nasdaq · Financials · Finance Services
Coeptis Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies, including cell therapy and antibody-based treatment candidates, to address unmet medical needs for patients with hard-to-treat malignancies. It primarily operates in the U.S., advancing its product pipeline across multiple oncology segments.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Armistice Capital, LLC | 4.99% | 1.9M | ▼ -4.97pp | 2024-11-14 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.